عربي
English
Quick links
Related sites
Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Login area | Sign up
Forgot your password? Click here
Let us help you
Read about the latest topics.
Download the new version of the MOPH app 
 
 
 
Be Responsible
#Raise your voice
Send us any Fraudulent Action or Enquiry so we can ALL contribute to make a Difference

Statement of the Minister of Public Health on al-Aridi's Case

 
Whereas … was making completely baseless accusations against the Minister, and publishing information that aimed at tarnishing the reputation of the Minister, which is considered as a legal violation that undermines the prestige of the Minister and the Ministry,

The Ministry of Public Health would like to clarify the following:
  1. The patients Riyad al-Aridi and Muhamad Bitar are affiliated to the National Social Security Fund, which means that the Ministry does not cover any hospitalization fees, whether partially or totally according to the system.
  2. The Office of the Minister of Public Health has only asked the hospital, as a humanitarian gesture, to help in reducing the bill and we appreciate the hospital doing so.
  3. All the mediation efforts regarding the patient al-Aridi have not prompted the minister to issue an exception by covering part of the expenses.
  4. The complainants would have rather addressed their statements to the concerned parties, i.e., the insurer of the patient, to issue an exceptional decision or update the current system so as to cover the patient’s treatment.
  5. The act of the tweeter user is punishable by law and attention has been drawn, several times ago, to similar cases.
    1
    ...
    6
    7
    8
    9
    10
    11
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All
ATC Name B/G Ingredients Dosage Form Price
H03BB02 TAPAZOLE B Methimazole (Thiamazole) - 5mg 5mg Tablet 565,694 L.L
H03BB02 THYROZOL B Methimazole (Thiamazole) - 5mg 5mg Tablet, film coated 233,829 L.L
H03BB02 THYROZOL B Methimazole (Thiamazole) - 10mg 10mg Tablet, film coated 326,554 L.L
C08DA51 TARKA B Verapamil - 180mg, Trandolapril - 2mg Capsule, modified release 2,422,948 L.L
C08DA51 TARKA B Verapamil - 240mg, Trandolapril - 4mg Tablet, modified release 3,797,532 L.L
L01FX29 TALVEY B Talquetamab - 2mg/ml 3mg/1.5ml Injectable solution 45,594,403 L.L
L01FX29 TALVEY B Talquetamab - 40mg/ml 40mg/ml Injectable solution 555,916,745 L.L
L04AX02 THALIDOMIDE BMS B Thalidomide - 50mg 50mg Capsule 27,387,764 L.L
L01CD02 TAXOTERE B Docetaxel (trihydrated) - 80mg/4ml 80mg/4ml Injectable concentrated solution+diluent 24,150,868 L.L
L04AX02 THALIDOMIDE CELGENE B Thalidomide - 50mg 50mg Capsule 27,387,764 L.L
J01AA04 TETRALYSAL B Lymecycline - 300mg 300mg Capsule 796,899 L.L
L01CD02 TAXOTERE B Docetaxel (trihydrated) - 80mg/4ml 80mg/4ml Injectable concentrated solution+diluent 24,150,868 L.L
L01CD02 TAXOTERE B Docetaxel (trihydrated) - 20mg/ml 20mg/ml Injectable concentrated solution+diluent 6,574,078 L.L
L01EB04 TAGRISSO B Osimertinib - 80mg 80mg Tablet, film coated L.L
L01CD02 TAXOTERE B Docetaxel (trihydrated) - 20mg/ml 20mg/ml Injectable concentrated solution+diluent 6,574,078 L.L
J01AA12 TYGACIL B Tigecycline - 50mg 50mg Injectable lyophilised powder for solution 25,356,524 L.L
L01EA03 TASIGNA B Nilotinib - 150mg 150mg Capsule L.L
C09AA05 TRITACE B Ramipril - 2.5mg 2.5mg Tablet 263,393 L.L
C09AA05 TRITACE B Ramipril - 5mg 5mg Tablet 509,316 L.L
L01EA03 TASIGNA B Nilotinib - 200mg 200mg Capsule L.L
C09AA05 TRITACE B Ramipril - 10mg 10mg Tablet 689,391 L.L
D06AX TRIPLE ANTIBIOTIC ORIGINAL OINTMENT Bacitracin - 400U, Neomycin (sulfate) - 3.5mg, Polymyxin B (sulfate) - 5000U 580,540 L.L
    1
    ...
    6
    7
    8
    9
    10
    11
Sitemap
© Copyrights reserved to Ministry of Public Health 2025